Compare with KREBS BIOCHEMICALS - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUVEN PHARMACEUTICALS vs KREBS BIOCHEMICALS - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SUVEN PHARMACEUTICALS KREBS BIOCHEMICALS SUVEN PHARMACEUTICALS/
KREBS BIOCHEMICALS
 
P/E (TTM) x 42.5 -11.6 - View Chart
P/BV x 11.1 - - View Chart
Dividend Yield % 0.4 0.0 -  

Financials

 SUVEN PHARMACEUTICALS   KREBS BIOCHEMICALS
EQUITY SHARE DATA
    SUVEN PHARMACEUTICALS
Mar-21
KREBS BIOCHEMICALS
Mar-21
SUVEN PHARMACEUTICALS/
KREBS BIOCHEMICALS
5-Yr Chart
Click to enlarge
High Rs525148 355.6%   
Low Rs10360 171.2%   
Sales per share (Unadj.) Rs39.727.4 144.9%  
Earnings per share (Unadj.) Rs12.1-14.5 -83.9%  
Cash flow per share (Unadj.) Rs13.4-11.8 -112.9%  
Dividends per share (Unadj.) Rs2.000-  
Avg Dividend yield %0.60-  
Book value per share (Unadj.) Rs46.4-23.9 -194.0%  
Shares outstanding (eoy) m254.5719.62 1,297.5%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x7.93.8 208.6%   
Avg P/E ratio x25.9-7.2 -360.4%  
P/CF ratio (eoy) x23.5-8.8 -267.8%  
Price / Book Value ratio x6.8-4.3 -155.8%  
Dividend payout %16.50-   
Avg Mkt Cap Rs m79,9532,039 3,922.0%   
No. of employees `000NANA-   
Total wages/salary Rs m762153 498.1%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m10,097537 1,880.3%  
Other income Rs m1426 2,292.6%   
Total revenues Rs m10,240543 1,885.0%   
Gross profit Rs m4,430-176 -2,520.4%  
Depreciation Rs m31651 617.4%   
Interest Rs m11763 185.8%   
Profit before tax Rs m4,139-284 -1,459.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,0530-   
Profit after tax Rs m3,086-284 -1,088.2%  
Gross profit margin %43.9-32.7 -134.0%  
Effective tax rate %25.40-   
Net profit margin %30.6-52.8 -57.9%  
BALANCE SHEET DATA
Current assets Rs m6,665214 3,112.1%   
Current liabilities Rs m3,215482 667.1%   
Net working cap to sales %34.2-49.9 -68.5%  
Current ratio x2.10.4 466.5%  
Inventory Days Days20054 370.3%  
Debtors Days Days37020 1,816.2%  
Net fixed assets Rs m9,0971,378 660.1%   
Share capital Rs m255196 129.7%   
"Free" reserves Rs m11,554-665 -1,736.7%   
Net worth Rs m11,808-469 -2,517.5%   
Long term debt Rs m3561,005 35.4%   
Total assets Rs m15,7621,592 990.0%  
Interest coverage x36.5-3.5 -1,037.6%   
Debt to equity ratio x0-2.1 -1.4%  
Sales to assets ratio x0.60.3 189.9%   
Return on assets %20.3-13.9 -146.5%  
Return on equity %26.160.5 43.2%  
Return on capital %35.0-41.2 -85.0%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m9,9020-   
Fx outflow Rs m1,36921 6,641.9%   
Net fx Rs m8,533-21 -41,404.2%   
CASH FLOW
From Operations Rs m3,834-146 -2,630.8%  
From Investments Rs m-3,114-225 1,381.0%  
From Financial Activity Rs m-766377 -203.3%  
Net Cashflow Rs m-455 -842.0%  

Share Holding

Indian Promoters % 60.0 72.7 82.5%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 13.8 0.0 138,400.0%  
FIIs % 8.0 0.0 80,300.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 40.0 27.3 146.7%  
Shareholders   96,532 8,571 1,126.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SUVEN PHARMACEUTICALS With:   SOLARA ACTIVE PHARMA SCIENCES  ROOPA INDUSTRIES  LACTOSE INDIA  VISTA PHARMA  ISTREET NETWORK  



Today's Market

Sensex Ends 383 Points Higher; Metal and Realty Stocks Rally(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended higher.

Related Views on News

SUVEN PHARMACEUTICALS 2020-21 Annual Report Analysis (Annual Result Update)

Sep 6, 2021 | Updated on Sep 6, 2021

Here's an analysis of the annual report of SUVEN PHARMACEUTICALS for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of SUVEN PHARMACEUTICALS. Also includes updates on the valuation of SUVEN PHARMACEUTICALS.

More Views on News

Most Popular

5 Green Energy Stocks to Watch as India Readies for a Revolution(Views On News)

Oct 13, 2021

The excitement around green energy stocks has opened up a huge contrarian opportunity in the traditional energy space.

Could HDFC Bank be a Big EV Winner? The Answer Will Surprise You...(Profit Hunter)

Oct 13, 2021

Why should investors take it for granted that India's Tesla will be one of the major auto stocks?

Tata Group Stocks are on Fire: Which one Should You Buy?(Profit Hunter)

Oct 15, 2021

Tata group stocks are on fire. Find out which one deserves your attention.

Massive Surge in the Shares of Tata Motors Today. Key Factors Favouring the Rally(Views On News)

Oct 13, 2021

Tata Motors zooms 23% after report of TPG investing Rs 75 bn in EV arm.

India's Big PSU Selloff: Watch Out for these Top Stocks(Views On News)

Oct 15, 2021

The government's plan to divest its stakes in PSUs could spark off a rally in these four stocks.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

SUVEN PHARMACEUTICALS SHARE PRICE


Oct 26, 2021 (Close)

TRACK SUVEN PHARMACEUTICALS

  • Track your investment in SUVEN PHARMACEUTICALS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON SUVEN PHARMACEUTICALS

SUVEN PHARMACEUTICALS 5-YR ANALYSIS

COMPARE SUVEN PHARMACEUTICALS WITH

MARKET STATS